What You Should Know:
– Wearlinq has secured $14M in Series A funding (plus $5M in venture debt) to scale its eWave device, the first continuous 6-lead wireless ECG that offers hospital-grade diagnostics in a…
Continue Reading
What You Should Know:
– Vitalis Ventures, an investment platform focused on AI-enabled care delivery has invested $15M in Drive Health to scale “Avery,” a Google-powered agentic AI platform designed to automate clinical workflows rather…
Continue Reading
Strategic Investment in Healthcare Technology
Charlotte-based Advocate Health has demonstrated its commitment to advancing healthcare technology by participating in a significant $10 million series A funding round for WellBeam, an innovative interoperability startup. This strategic…
Continue Reading
What You Should Know:
– WellBeam, a healthcare technology company, announced that it has successfully raised $10M in Series A funding led by Wittington Ventures and included participation from F-Prime, Advocate Health, and Oncology Ventures.
–…
Continue Reading
What You Should Know:
– FamilyWell Health, an integrated women’s mental health company, raises $8M in Series A funding led by New Markets Venture Partners with participation from existing and new investors– .406 Ventures, GreyMatter…
Continue Reading
What You Should Know:
– voize, the AI company redefining nursing care, has secured $50M in Series A funding led by Balderton Capital.
– The investment will fuel its expansion into the U.S. and Europe, accelerating…
Continue Reading
What You Should Know:
– Joy, a platform revolutionizing the parenting experience secures $14M in Series A funding co-led by Forerunner and Raga Partners, with participation from Magnify Ventures, Ingeborg Investments, Shazi Visram, Rogue Venture…
Continue Reading
What You Should Know:
– Evidium, an innovative healthcare artificial intelligence company, has announced the close of its Series A equity funding round co-led by Health2047, the venture studio of the American Medical Association (AMA),…
Continue Reading
What You Should Know:
– Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series…
Continue Reading
Series A Investment Will Advance the Company’s Efforts to Give Patients the Power to Drive Research on Rare Diseases and Chronic Conditions
Folia Health, the patient-driven health company and pioneer of home-reported outcomes (HROs), committed…
